Robert E. Funck, Jr.
Equibles does not estimate personal net worth.
Get an email with a short summary when Abbott Laboratories publishes a filing, an earnings call transcript or a press release.
Get ABT alertsAbout Robert E. Funck, Jr.
Robert E. Funck, Jr. is recorded as CFO at Abbott Laboratories (ABT) since March 1, 2020. Abbott Laboratories reported in an 8-K filed May 1, 2024 that Robert E. Funck, Jr. retired as Executive Vice President, Finance, effective July 1, 2024. Abbott Laboratories reported in an 8-K filed June 12, 2023 that Robert E. Funck, Jr. was appointed Executive Vice President, Finance, effective September 1, 2023. Abbott Laboratories is classified in the Medical Devices industry within the Healthcare sector. Other leadership on record at Abbott Laboratories includes Robert B. Ford (CEO, Chairman and Board Member), Philip P. Boudreau (CFO), Claire Babineaux-Fontenot (Board Member) and 7 others.
“On April 26, 2024, Robert E. Funck, Jr., Executive Vice President, Finance, informed Abbott Laboratories that he plans to retire from the company after 36 years of service, effective July 1, 2024.”
“Effective September 1, 2023, Robert E. Funck, Jr. has been appointed Executive Vice President, Finance”
Affiliation history
-
Abbott Laboratories (ABT)
SEC 8-K
Current2023-09-01–present
-
Current
2020-03-01–present
-
Abbott Laboratories (ABT)
SEC 8-K
2023-09-01–2024-07-01
Company network
Leadership on record at Abbott Laboratories
- Robert B. Ford CEO, Chairman, Board Member
- Philip P. Boudreau CFO
- Claire Babineaux-Fontenot Board Member
- Daniel J. Starks Board Member
- Darren W. McDew Board Member
- John G. Stratton Board Member
- Kevin Conroy Board Member
- Michael F. Roman Board Member
- Michael G. O’Grady Board Member
- Michelle A. Kumbier Board Member